Product Information
Name:MGCD-265 analog
Synonyms:
- MGCD-265
- Glesatinib analog
Brand:Targetmol
Description:Glesatinib, an oral tyrosine kinase inhibitor, targets c-Met and VEGFR2 with IC50s of 29 nM and 10 nM, may treat cancer.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:517.6
Formula:C26H20FN5O2S2
Purity:98.06% - 98.68%
Color/Form:Solid
Technical inquiry about: MGCD-265 analog
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.